Differentiated Thyroid Cancer Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University40 enrolled1 locationNCT06970353
Recruiting
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Differentiated Thyroid Cancer
Shanghai 6th People's Hospital500 enrolled1 locationNCT06671184
Recruiting
Phase 2
Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Differentiated Thyroid Cancer
Fudan University32 enrolled1 locationNCT05989425